| Literature DB >> 35774224 |
Yan Gao1, Zeyu Tian1, Qian Liu1, Ting Wang1, Lee-Kiat Ban2, Henry Hsin-Chung Lee2,3, Akihiro Umezawa4, Abdulrahman I Almansour5, Natarajan Arumugam5, Raju Suresh Kumar5, Qingsong Ye6,7, Akon Higuchi1,4,8,9, Hao Chen1, Tzu-Cheng Sung1.
Abstract
Stem cells serve as an ideal source of tissue regeneration therapy because of their high stemness properties and regenerative activities. Mesenchymal stem cells (MSCs) are considered an excellent source of stem cell therapy because MSCs can be easily obtained without ethical concern and can differentiate into most types of cells in the human body. We prepared cell culture materials combined with synthetic polymeric materials of poly-N-isopropylacrylamide-co-butyl acrylate (PN) and extracellular matrix proteins to investigate the effect of cell culture biomaterials on the differentiation of dental pulp stem cells (DPSCs) into neuronal cells. The DPSCs cultured on poly-L-ornithine (PLO)-coated (TPS-PLO) plates and PLO and PN-coated (TPS-PLO-PN) plates showed excellent neuronal marker (βIII-tubulin and nestin) expression and the highest expansion rate among the culture plates investigated in this study. This result suggests that the TPS-PLO and TPS-PN-PLO plates maintained stable DPSCs proliferation and had good capabilities of differentiating into neuronal cells. TPS-PLO and TPS-PN-PLO plates may have high potentials as cell culture biomaterials for the differentiation of MSCs into several neural cells, such as cells in the central nervous system, retinal cells, retinal organoids and oligodendrocytes, which will expand the sources of cells for stem cell therapies in the future.Entities:
Keywords: cell therapy; dental pulp stem cells; neuronal cell differentiation; poly-L-ornithine; poly-N-isopropylacrylamide-butyl acrylate; synthetic cell culture polymer
Year: 2022 PMID: 35774224 PMCID: PMC9237518 DOI: 10.3389/fcell.2022.893241
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X
Materials used in this study.
| Materials | Abbreviations | Cat. No. | Company |
|---|---|---|---|
| ECM | |||
| Recombinant vitronectin | rVT | A14700 | Thermo Fisher Scientific Inc. (Waltham, MA, United States) |
| Biolaminin 521 | LN | BLA-LN521-05 | BioLamina (Tokyo, Japan) |
| Poly-L-Ornithine | PLO | A-004-C | Merck (Darmstadt, Germany) |
| Chemicals and polymers | |||
| Phosphate-buffered saline | PBS | c20012500BT | Thermo Fisher Scientific Inc. (Waltham, MA, United States) |
| Penicillin-Streptomycin | PS | 15140122 | Thermo Fisher Scientific Inc. (Waltham, MA, United States) |
| Dulbecco’s phosphate-buffered saline | DPBS | 14040141 | Thermo Fisher Scientific Inc. (Waltham, MA, United States) |
| Trypsin-EDTA (0.25%) solution | Trypsin-EDTA | 25200-072 | Thermo Fisher Scientific Inc. (Waltham, MA, United States) |
| Culture medium and component | |||
| | α-MEM | 12571048 | Thermo Fisher Scientific Inc. (Waltham, MA, United States) |
| Fetal bovine serum | FBS | 10091148 | Thermo Fisher Scientific Inc. (Waltham, MA, United States) |
| Neurobasal-A medium | Neurobasal-A | 10888022 | Thermo Fisher Scientific Inc. (Waltham, MA, United States) |
| Human recombinant basic fibroblast growth factor | bFGF | AF-100-18B | Peprotech (Rocky Hill, NJ, United States) |
| Human epidermal growth factor | EGF | AF-100-15 | Peprotech (Rocky Hill, NJ, United States) |
| B27 supplement | B27 | 17504044 | Thermo Fisher Scientific Inc. (Waltham, MA, United States) |
| Poly ( | PN | 762881 | Sigma-Aldrich (St. Louis, MO, United States) |
| Antibodies | |||
| CD73 monoclonal antibody, FITC | CD 73 | 11-0739-41 | Thermo Fisher Scientific Inc. (Waltham, MA, United States) |
| CD105 monoclonal antibody, PE | CD 105 | 12-1057-42 | Thermo Fisher Scientific Inc. (Waltham, MA, United States) |
| CD34 monoclonal antibody, FITC | CD34 | 11-034941 | Thermo Fisher Scientific Inc. (Waltham, MA, United States) |
| Mouse IgG1 kappa isotype, FITC | IgG1 isotype-FITC | 11-471482 | Thermo Fisher Scientific Inc. (Waltham, MA, United States) |
| Mouse IgG1 kappa Isotype, PE | IgG1 isotype-PE | 12-4714-82 | Thermo Fisher Scientific Inc. (Waltham, MA, United States) |
| Anti-nestin antibody | Nestin antibody | ab176571 | Abcam (Milton, Cambridge, United Kingdom) |
| Anti-beta III tubulin antibody |
| ab78078 | Abcam (Milton, Cambridge, United Kingdom) |
| Goat anti-rabbit IgG H&L antibody (AlexaFluor® 488) | 488-Goat anti-rabbit IgG H&L antibody | ab150077 | Abcam (Milton, Cambridge, United Kingdom) |
| Goat anti-mouse IgG H&L antibody (Alexa Fluor® 555) | 555-Goat anti-mouse IgG H&L antibody | ab150114 | Abcam (Milton, Cambridge, United Kingdom) |
FIGURE 1Experimental scheme of DPSCs extraction, culture, characterization and differentiation into neuronal cells.
FIGURE 2Characterization of TPS, TPS-PN, TPS-ECM, TPS-PLO, TPS-PN-ECM and TPS-PN-PLO plates. (A) High-resolution XPS spectra of the C1s peaks on the surface of TPS (a), TPS-PN (b), TPS-rVT (c), TPS-PN-rVT (d), TPS-LN (e), TPS-PN-LN (f), TPS-PLO (g) and TPS-PN-PLO (h) plates. (B) High-resolution XPS spectra of the N1s peaks on the surface of TPS (a), TPS-PN (b), TPS-rVT (c), TPS-PN-rVT (d), TPS-LN (e), TPS-PN-LN (f), TPS-PLO (g) and TPS-PN-PLO (h) plates. (C) The nitrogen to carbon (N/C) atomic ratios on the surface of TPS, TPS-PN, TPS-ECM, TPS-PLO, TPS-PN-ECM and TPS-PN-PLO plates. *p < 0.05. **p > 0.05.
FIGURE 3Cultivation of DPSCs on TPS, TPS-PN, TPS-ECM, TPS-PLO, TPS-PN-ECM and TPS-PN-PLO plates for five passages. (A) The timeline of primary DPSCs culturing and expansion. (B) The morphologies of primary DPSCs (day 5 at P0) (a) and day 5 at P5 (b–i) on the TPS (b), TPS-rVT (c), TPS-LN (d), TPS-PLO (e), TPS-PN (f), TPS-PN-rVT (g), TPS-PN-LN (h) and TPS-PN-PLO (i) plates. (C) The doubling time of DPSCs on TPS, TPS-PN, TPS-ECM, TPS-PLO, TPS-PN-ECM and TPS-PN-PLO plates at passages 3-5. The bar indicates 200 μm (a) and 50 μm (b–i). *p < 0.05. **p > 0.05.
FIGURE 4Expression of MSC markers [CD73 (i) and CD105 (ii)] and hematopoietic marker [CD34 (iii)] in DPSCs cultured on TPS (A), TPS-PN (B), TPS-rVT (C), TPS-PN-rVT (D), TPS-LN (E), TPS-PN-LN (F), TPS-PLO (G) and TPS-PN-PLO plates (H).
FIGURE 5Differentiation of DPSCs into neuronal cells after five passages of cultivation on TPS, TPS-PN, TPS-ECM, TPS-PLO, TPS-PN-ECM and TPS-PN-PLO plates. (A) The timeline of the induction of DPSCs differentiation into neuronal cells. (B) The morphologies of DPSCs-derived neuronal cells (i) and the immunohistochemical assay of βIII-tubulin [(ii), green] and nestin [(iii), red)] expression on the TPS (a), TPS-PN (b), TPS-rVT (c), TPS-PN-rVT (d), TPS-LN (e), TPS-PN-LN (f), TPS-PLO (g) and TPS-PN-PLO (h) plates. The photo (iv) was the merged photos of (ii) and (iii). The scale bar indicates 100 μm.
FIGURE 6Characterization of DPSCs-derived neuronal cells after five passages of DPSCs cultivation on TPS, TPS-PN, TPS-ECM, TPS-PLO, TPS-PN-ECM and TPS-PN-PLO plates. (A) Flow cytometry spectra of nestin expression on DPSCs-derived neuronal cells cultivated on TPS (a), TPS-PN (b), TPS-LN (c), TPS-PN-LN (d), TPS-rVT (e), TPS-PN-rVT (f), TPS-PLO (g) and TPS-PN-PLO (h) plates. (B) Nestin expression ratio cultured on DPSCs-derived neuronal cells, which were cultivated on TPS, TPS-PN, TPS-ECM, TPS-PLO, TPS-PN-ECM and TPS-PN-PLO plates. *p < 0.05. **p > 0.05. (C) βIII tubulin expression ratio cultured on DPSCs-derived neuronal cells, which were cultivated on TPS, TPS-PN, TPS-ECM, TPS-PLO, TPS-PN-ECM and TPS-PN-PLO plates. *p < 0.05. (D) Dependence of the averaged neuronal expression of DPSC-derived neuronal cells on the doubling time of DPSCs cultured on TPS, TPS-PN, TPS-ECM, TPS-PLO, TPS-PN-ECM and TPS-PN-PLO plates.